Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder
Award Notice Posted
- Solicitation number
- 75N95021D00024
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Murty Pharmaceuticals, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95021D00024-75N95021F00001 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Lexington, Kentucky 40509, United States
Notice details come from SAM.gov. Updated .
Notice text
On September 17, 2021, in response to the requirements of Request for Proposal 75N95020R00036, the National Institute on Drug Abuse (NIDA) awarded an indefinite delivery, indefinite quantity (task order) type contract with an ordering period of five (5) years. The Government anticipates fixed-price & cost reimbursement task orders that shall be fully funded on and after contract award. At the time of award of Contract No. 75N95021D00024, NIDA awarded Task Order No. 75N95021F00001 in the amount of $309,087, to meet the Guaranteed Contract Minimum amount of $10,000. The total contract and obligated amount shall not exceed $7,000,000.
Awarded contract 75N95021D00024 to MURTY PHARMACEUTICALS, INC. for 7000000.00 on 2021-09-17.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder | Solicitation | |
| Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder | Pre-Solicitation | |
| Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorder | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity